Insmed Return on Equity

Insmed (INSM) currently reports a ROE of -83.39%. That is below the Healthcare sector average of -75.84%. Use the charts on this page to explore Insmed's ROE history and peer comparisons.

Insmed's ROE of -83.39% is lower than the Healthcare sector average of -75.84%. That is roughly 10.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Insmed's current -83.39% should be judged against Healthcare norms (sector average: -75.84%) and against INSM's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -83.39%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Insmed, and consider following INSM for alerts when major investors trade the stock.

Insmed is classified in the Healthcare sector. On ROE, it currently shows -83.39% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INSM with unrelated industries.